RYVAX
Price
$286.85
Change
+$2.16 (+0.76%)
Updated
Jul 13 closing price
Net Assets
36.24M
VENAX
Price
$80.01
Change
+$2.29 (+2.95%)
Updated
Jul 13 closing price
Net Assets
11.08B
Interact to see
Advertisement

RYVAX vs VENAX

RYVAX vs VENAX Comparison Chart in %
View a ticker or compare two or three
VS
RYVAX vs. VENAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVAX is a Buy and VENAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VENAX has more cash in the bank: 11.1B vs. RYVAX (36.2M). VENAX pays higher dividends than RYVAX: VENAX (2.68) vs RYVAX (0.44). RYVAX was incepted earlier than VENAX: RYVAX (28 years) vs VENAX (22 years). RYVAX (1.68) is less costly to investors than VENAX (0.09). RYVAX is a more actively managed with annual turnover of: 420.00 vs. VENAX (11.00). RYVAX has a lower initial minimum investment than VENAX: RYVAX (2500) vs VENAX (100000). RYVAX annual gain was more profitable for investors over the last year : 59.35 vs. VENAX (24.31). VENAX return over 5 years is better than : 118.64 vs. RYVAX (79.01).
RYVAXVENAXRYVAX / VENAX
Total Expense Ratio1.630.091,811%
Annual Report Gross Expense Ratio1.680.091,867%
Fund Existence28 years22 years-
Gain YTD38.17223.542162%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets36.2M11.1B0%
Annual Yield % from dividends0.442.6817%
Returns for 1 year59.3524.31244%
Returns for 3 years28.7837.3877%
Returns for 5 years79.01118.6467%
Returns for 10 years-30.4562.17-49%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
REQTX46.49N/A
N/A
Russell Investments Sustainable Equity S
ARYDX14.98N/A
N/A
American Century Global Real Estate R6
CAMUX19.40N/A
N/A
Cambiar SMID Institutional
MXHAX15.01N/A
N/A
Empower Large Cap Value Inv II
FCCGX31.14N/A
N/A
Fidelity Advisor Small Cap Growth C